USNA
Research Snapshot
Static fundamentals, valuation context, and investor signals for USANA HEALTH SCIENCES, INC. (USNA).
DCF ready
Valuation
N/A
EV/FCF, N/A FCF yield
Quality
2.0%
ROIC, 0.9% FCF margin
Growth
-4.0%
5Y sales (revenue) CAGR
Balance sheet
0.0x
Debt/equity, 2.2x current ratio
Superinvestors
1
Top: Richard Pzena (0.1%)
Strengths to research
- Debt/equity looks manageable at 0.0x.
- 10 annual periods are available for trend analysis.
Watchouts
- Five-year revenue trend is negative at -4.0%.
- Valuation multiples are limited or unavailable.
Annual data: 10 periods
Quarterly data: 22 periods
Stock snapshot: May 25, 2026
Static dataset: May 25, 2026
Quality Scorecard
Build-time composite score for USNA.
Grade D
37
/ 100
Financial Charts
No financial data available for USNA (annual).
1 superinvestors own USNA
Current quarter ownership and quarter-over-quarter share changes.
Superinvestor ownership
| Fund | Shares | Value | % Portfolio | QoQ Change |
|---|---|---|---|---|
| Richard Pzena Hancock Classic Value | 1,108,933 | $19M | 0.06% | 0.0% |